» Articles » PMID: 35471131

Midterm Outcomes of BeGraft Stent Grafts Used As Bridging Stents in Fenestrated Endovascular Aortic Aneurysm Repair

Overview
Journal J Endovasc Ther
Publisher Sage Publications
Date 2022 Apr 26
PMID 35471131
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Fenestrated endovascular aneurysm repair (fEVAR) is established for the treatment of juxtarenal, pararenal, and thoracoabdominal aortic aneurysms (TAAAs). Bridging stents are used to connect the main body of the stent graft to the aortic branch vessels. Complications related to the bridging stents compromise the durability of the repair and require urgent re-intervention. Here we present the midterm results of the BeGraft stent graft system used for fEVAR.

Materials And Method: All consecutive patients treated with fEVAR and the current BeGraft Peripheral Stent Graft between November 2015 and September 2016 were included.

Results: Thirty-nine consecutive patients (38 men) were enrolled and 101 BeGraft second-generation stent grafts were implanted. The median aneurysm diameter was 60 mm (54.5-67.0 mm). Aneurysms were juxtarenal and pararenal (19/39, 48.1%), type 4 TAAA (3/39, 7.7%), type 1, 2, and 3 TAAA (7/39, 17.8%), type 5 TAAA (4/39, 10.2%), and 15.4% (6/39) had a type I endoleak following a previous EVAR. Fifty-five BeGrafts were implanted in mesenteric arteries (22 in coeliac trunks, 31 in the superior mesenteric artery, and 2 in a hepatic or splenic artery) and 46 into renal arteries (24 right and 22 left). The renal artery diameters were 5, 6, 7, and 8 mm in 9, 7, 26, and 4 patients, respectively. Mesenteric arteries were exclusively stented with 9 and 10 mm diameter devices. The median follow-up was 33 months (IQ25 17-IQ75 36). During follow-up, 11 patients died (28%) from non-aneurysm-related causes. The overall patency rates for bridging stents were 98% and 97% at 1 and 2 years, respectively, with a freedom from secondary procedure rate on BeGraft stent grafts of 96% (97/101). All events occurred on stents implanted in renal arteries.

Conclusion: Early favorable outcomes are confirmed during longer term follow-up. Vigilant surveillance is required.

Citing Articles

Analysis of Target Vessel Instability in Fenestrated Endovascular Repair (f-EVAR) in Thoraco-Abdominal Aortic Pathologies.

Becker D, Sikman L, Ali A, Mosbahi S, Prendes C, Stana J J Clin Med. 2024; 13(10).

PMID: 38792439 PMC: 11122549. DOI: 10.3390/jcm13102898.

References
1.
Mastracci T, Carrell T, Constantinou J, Dias N, Martin-Gonzalez T, Katsargyris A . Editor's Choice - Effect of Branch Stent Choice on Branch-related Outcomes in Complex Aortic Repair. Eur J Vasc Endovasc Surg. 2016; 51(4):536-42. DOI: 10.1016/j.ejvs.2015.12.046. View

2.
Tenorio E, Karkkainen J, Mendes B, DeMartino R, Macedo T, Diderrich A . Outcomes of directional branches using self-expandable or balloon-expandable stent grafts during endovascular repair of thoracoabdominal aortic aneurysms. J Vasc Surg. 2019; 71(5):1489-1502.e6. DOI: 10.1016/j.jvs.2019.07.079. View

3.
Verhoeven E, Katsargyris A, Bekkema F, Oikonomou K, Zeebregts C, Ritter W . Editor's Choice - Ten-year Experience with Endovascular Repair of Thoracoabdominal Aortic Aneurysms: Results from 166 Consecutive Patients. Eur J Vasc Endovasc Surg. 2015; 49(5):524-31. DOI: 10.1016/j.ejvs.2014.11.018. View

4.
Torsello G, Herten M, Muller M, Frank A, Torsello G, Austermann M . Comparison of the Biomechanical Properties of the Advanta V12/iCast and Viabahn Stent-Grafts as Bridging Devices in Fenestrated Endografts: An In Vitro Study. J Endovasc Ther. 2020; 27(2):258-265. DOI: 10.1177/1526602820908602. View

5.
Spear R, Sobocinski J, Hertault A, Delloye M, Azzauiu R, Fabre D . One Year Outcomes of 101 BeGraft Stent Grafts used as Bridging Stents in Fenestrated Endovascular Repairs. Eur J Vasc Endovasc Surg. 2018; 55(4):504-510. DOI: 10.1016/j.ejvs.2018.01.023. View